single stranded mrna with 5? capping that encodes the fusion protein f of the respiratory syncytial virus stabilized in the prefusion conformation

Italy

Drugs containing this active substance

  • MRESVIA

    It is a vaccine that helps protect adults over 60 years of age from respiratory syncytial virus (RSV). It can also be used by adults between 18 and 59 years of age who are at higher risk of developing diseases caused by this virus.

    Form: solution for injection

    Active substance Dosage
    single stranded mrna with 5? capping that encodes the fusion protein f of the respiratory syncytial virus stabilized in the prefusion conformation -

    ATC: J07BX05

    Manufacturer: MODERNA BIOTECH SPAIN, S.L.